These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16847066)
21. Differential expression of d-type cyclins in podocytes in vitro and in vivo. Petermann A; Hiromura K; Pippin J; Blonski M; Couser WG; Kopp J; Mundel P; Shankland SJ Am J Pathol; 2004 Apr; 164(4):1417-24. PubMed ID: 15039229 [TBL] [Abstract][Full Text] [Related]
22. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer. Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688 [TBL] [Abstract][Full Text] [Related]
23. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis. Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941 [TBL] [Abstract][Full Text] [Related]
24. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Shankland SJ; Hugo C; Coats SR; Nangaku M; Pichler RH; Gordon KL; Pippin J; Roberts JM; Couser WG; Johnson RJ Kidney Int; 1996 Oct; 50(4):1230-9. PubMed ID: 8887282 [TBL] [Abstract][Full Text] [Related]
25. The cyclin-dependent kinase inhibitor p21(CIP1/WAF1) blocks paclitaxel-induced G2M arrest and attenuates mitochondrial injury and apoptosis in p53-null human leukemia cells. Ahmed W; Rahmani M; Dent P; Grant S Cell Cycle; 2004 Oct; 3(10):1305-11. PubMed ID: 15467449 [TBL] [Abstract][Full Text] [Related]
26. The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1). Keblusek P; Dorsman JC; Teunisse AF; Teunissen H; van der Eb AJ; Zantema A J Gen Virol; 1999 Feb; 80 ( Pt 2)():381-390. PubMed ID: 10073698 [TBL] [Abstract][Full Text] [Related]
27. Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. Taniguchi Y; Pippin JW; Hagmann H; Krofft RD; Chang AM; Zhang J; Terada Y; Brinkkoetter P; Shankland SJ Am J Physiol Renal Physiol; 2012 May; 302(9):F1161-71. PubMed ID: 22262481 [TBL] [Abstract][Full Text] [Related]
28. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1). Yang F; von Knethen A; Brüne B J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661 [TBL] [Abstract][Full Text] [Related]
29. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. Weiss RH; Joo A; Randour C J Biol Chem; 2000 Apr; 275(14):10285-90. PubMed ID: 10744715 [TBL] [Abstract][Full Text] [Related]
30. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma. Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681 [TBL] [Abstract][Full Text] [Related]
31. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357 [TBL] [Abstract][Full Text] [Related]
33. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589 [TBL] [Abstract][Full Text] [Related]
34. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Chopin V; Toillon RA; Jouy N; Le Bourhis X Oncogene; 2004 Jan; 23(1):21-9. PubMed ID: 14712207 [TBL] [Abstract][Full Text] [Related]
35. The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Lincet H; Poulain L; Remy JS; Deslandes E; Duigou F; Gauduchon P; Staedel C Cancer Lett; 2000 Dec; 161(1):17-26. PubMed ID: 11078909 [TBL] [Abstract][Full Text] [Related]
36. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Chen X; Bargonetti J; Prives C Cancer Res; 1995 Oct; 55(19):4257-63. PubMed ID: 7671232 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1). Tanabe T; Kominsky SL; Subramaniam PS; Johnson HM; Torres BA J Neurooncol; 2000 Jul; 48(3):225-32. PubMed ID: 11100820 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Liu S; Bishop WR; Liu M Drug Resist Updat; 2003 Aug; 6(4):183-95. PubMed ID: 12962684 [TBL] [Abstract][Full Text] [Related]
39. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Missero C; Calautti E; Eckner R; Chin J; Tsai LH; Livingston DM; Dotto GP Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5451-5. PubMed ID: 7777529 [TBL] [Abstract][Full Text] [Related]
40. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1). Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]